Aptevo Therapeutics Inc. (NASDAQ:APVO) Short Interest Update

Aptevo Therapeutics Inc. (NASDAQ:APVO) was the target of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 23,500 shares, a drop of 46.2% from the January 31st total of 43,700 shares. Based on an average trading volume of 197,200 shares, the short-interest ratio is presently 0.1 days. Approximately 1.6% of the shares of the company are short sold.

Aptevo Therapeutics Trading Up 6.4 %

Shares of NASDAQ APVO opened at $3.82 on Friday. Aptevo Therapeutics has a 12-month low of $3.01 and a 12-month high of $399.60. The stock has a 50 day simple moving average of $4.26 and a 200-day simple moving average of $209.67.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Aptevo Therapeutics in a research note on Monday, December 9th. They set a “sell” rating for the company.

About Aptevo Therapeutics

Aptevo Therapeutics Inc, a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. It develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.